An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration datesort descending
What is Biomarker Testing, and Why Is It Important? 1.00 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Evaluating Immune Checkpoint Inhibition Response Biomarkers 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Clinical Scenario #1: Applying Biomarkers in Risk Stratification of Localized Prostate Cancer 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Clinical Scenario #2: Applying Biomarkers in Breast Cancer 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Clinical Scenario #3: Applying Biomarkers in Central Nervous System Cancers 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Clinical Scenario #4: Applying Biomarkers in Non-Small Cell Lung Cancer 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Clinical Scenario #5: Applying Biomarkers in Biliary Tract Cancers 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
What Drives Reimbursement for Biomarker Testing? 1.25 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Archived Monthly Oncology Tumor Boards: Advances in Systemic Treatment of Metastatic Cutaneous Melanoma 1.00 06/29/2023 - 12:00am to 06/29/2024 - 12:00am
Monthly Oncology Tumor Boards: Management of Pheochromocytoma and Paraganglioma 1.00 06/29/2023 - 12:00am to 07/21/2024 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: Updates on Targeted Therapy for the Treatment of Thyroid Carcinoma 1.00 06/30/2023 - 12:00am to 06/28/2024 - 12:00am
NCCN Guidelines® Insights - Biliary Tract Cancers, Version 2.2023 1.00 07/10/2023 - 12:00am to 07/10/2024 - 12:00am
The Evolving Landscape in CLL/SLL: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations 1.75 07/21/2023 - 12:00am to 07/21/2024 - 12:00am
Advances in Hepatocellular and Biliary Tract Cancers Impacting Patient Outcomes 1.75 07/21/2023 - 12:00am to 07/21/2024 - 12:00am
Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future 1.75 07/21/2023 - 12:00am to 07/21/2024 - 12:00am

Pages